Multiple Biomarker Approach to Risk Stratification in COVID-19.
作者信息
Smilowitz Nathaniel R, Nguy Vuthy, Aphinyanaphongs Yindalon, Newman Jonathan D, Xia Yuhe, Reynolds Harmony R, Hochman Judith S, Fishman Glenn I, Berger Jeffrey S
机构信息
Leon H. Charney Division of Cardiology, Department of Medicine (N.R.S., J.S.N., Y.X., H.R.R., J.S.H., G.I.F., J.S.B.), School of Medicine, New York University.
Department of Medicine, VA New York Harbor Healthcare System (N.R.S.).
出版信息
Circulation. 2021 Mar 30;143(13):1338-1340. doi: 10.1161/CIRCULATIONAHA.120.053311. Epub 2021 Feb 15.
Abstract
摘要
相似文献
1
Multiple Biomarker Approach to Risk Stratification in COVID-19.COVID-19风险分层的多种生物标志物方法
Circulation. 2021 Mar 30;143(13):1338-1340. doi: 10.1161/CIRCULATIONAHA.120.053311. Epub 2021 Feb 15.
2
Troponin and Other Biomarker Levels and Outcomes Among Patients Hospitalized With COVID-19: Derivation and Validation of the HAT COVID-19 Mortality Risk Score.肌钙蛋白和其他生物标志物水平与 COVID-19 住院患者结局：HAT COVID-19 死亡率风险评分的推导和验证。
J Am Heart Assoc. 2021 Mar 16;10(6):e018477. doi: 10.1161/JAHA.120.018477. Epub 2020 Oct 30.
3
Biomarker evaluation for prognostic stratification of patients with COVID-19: the added value of quantitative chest CT.用于 COVID-19 患者预后分层的生物标志物评估：定量胸部 CT 的附加价值。
Biomark Med. 2022 Mar;16(4):291-301. doi: 10.2217/bmm-2021-0536. Epub 2022 Feb 18.
4
Utility of inflammatory biomarkers in patients with COVID-19 infections: Bahrain experience.炎症生物标志物在 COVID-19 感染患者中的应用：巴林经验。
Biomark Med. 2021 Jun;15(8):541-549. doi: 10.2217/bmm-2020-0422. Epub 2021 May 14.
5
Biomarkers for Prognosis and Treatment Response in COVID-19 Patients.用于 COVID-19 患者预后和治疗反应的生物标志物。
Ann Lab Med. 2021 Nov 1;41(6):540-548. doi: 10.3343/alm.2021.41.6.540.
6
High mortality among hospitalized adult patients with COVID-19 pneumonia in Peru: A single centre retrospective cohort study.秘鲁住院成人 COVID-19 肺炎患者死亡率高：一项单中心回顾性队列研究。
PLoS One. 2022 Mar 8;17(3):e0265089. doi: 10.1371/journal.pone.0265089. eCollection 2022.
7
Biomarkers of Cytokine Release Syndrome Predict Disease Severity and Mortality From COVID-19 in Kidney Transplant Recipients.细胞因子释放综合征的生物标志物可预测肾移植受者 COVID-19 疾病的严重程度和死亡率。
Transplantation. 2021 Jan 1;105(1):158-169. doi: 10.1097/TP.0000000000003480.
8
The relationship between cardiac injury, inflammation and coagulation in predicting COVID-19 outcome.心脏损伤、炎症与凝血在预测 COVID-19 结局中的关系。
Sci Rep. 2021 Mar 22;11(1):6515. doi: 10.1038/s41598-021-85646-z.
9
Myoglobin and C-reactive protein are efficient and reliable early predictors of COVID-19 associated mortality.肌红蛋白和 C 反应蛋白是 COVID-19 相关死亡率的有效且可靠的早期预测指标。
Sci Rep. 2021 Mar 16;11(1):5975. doi: 10.1038/s41598-021-85426-9.
10
Assessment of the Relationship between Mortality and Troponin I Levels in Hospitalized Patients with the Novel Coronavirus (COVID-19).新型冠状病毒（COVID-19）住院患者死亡率与肌钙蛋白I水平之间关系的评估
Medicina (Kaunas). 2020 Dec 13;56(12):693. doi: 10.3390/medicina56120693.
引用本文的文献
1
Utility of Protein Markers in COVID-19 Patients.蛋白质标志物在新冠病毒感染患者中的应用
Int J Mol Sci. 2025 Jan 14;26(2):653. doi: 10.3390/ijms26020653.
2
Association of COVID-19 with acute and post-acute risk of multiple different complications and mortality in patients infected with omicron variant stratified by initial disease severity: a cohort study in Hong Kong.奥密克戎变异株感染患者中，按初始疾病严重程度分层的 COVID-19 与多种不同并发症和死亡的急性和亚急性风险的相关性：香港的一项队列研究。
BMC Med. 2024 Oct 14;22(1):461. doi: 10.1186/s12916-024-03630-6.
3
Associations of psychological wellbeing with COVID-19 hospitalization and mortality in adults aged 50 years or older from 25 European countries and Israel.25 个欧洲国家和以色列 50 岁及以上成年人的心理健康与 COVID-19 住院和死亡的关联。
Front Public Health. 2023 May 4;11:1124915. doi: 10.3389/fpubh.2023.1124915. eCollection 2023.
4
Title: Serious COVID-19 may have a causal relationship with myocardial injury: A Mendelian randomization study.标题：重症新型冠状病毒肺炎可能与心肌损伤存在因果关系：一项孟德尔随机化研究。
Front Genet. 2023 Mar 23;14:1135887. doi: 10.3389/fgene.2023.1135887. eCollection 2023.
5
Exploratory COVID-19 death risk score based on basic laboratory tests and physiological clinical measurements.基于基础实验室检查和生理临床测量的探索性新冠死亡风险评分
World J Emerg Med. 2022;13(6):453-458. doi: 10.5847/wjem.j.1920-8642.2022.103.
6
Fibrinogen-to-Albumin Ratio and Blood Urea Nitrogen-to-Albumin Ratio in COVID-19 Patients: A Systematic Review and Meta-Analysis.COVID-19患者的纤维蛋白原与白蛋白比值和血尿素氮与白蛋白比值：一项系统评价和荟萃分析
Trop Med Infect Dis. 2022 Jul 27;7(8):150. doi: 10.3390/tropicalmed7080150.
7
Early antithrombotic post-discharge therapy using prophylactic DOAC or dipyridamole improves long-term survival and cardiovascular outcomes in hospitalized COVID-19 survivors.出院后早期使用预防性直接口服抗凝剂（DOAC）或双嘧达莫进行抗血栓治疗可改善住院COVID-19幸存者的长期生存率和心血管结局。
Front Cardiovasc Med. 2022 Jul 29;9:916156. doi: 10.3389/fcvm.2022.916156. eCollection 2022.
8
Soluble urokinase Plasminogen Activator Receptor (suPAR) levels are predictive of COVID-19 severity: an Italian experience.可溶性尿激酶型纤溶酶原激活物受体 (suPAR) 水平可预测 COVID-19 严重程度：意大利经验。
Clin Immunol. 2022 Sep;242:109091. doi: 10.1016/j.clim.2022.109091. Epub 2022 Aug 6.
9
Serial cardiac biomarkers for risk stratification of patients with COVID-19.用于 COVID-19 患者风险分层的连续心脏生物标志物。
Clin Biochem. 2022 Sep;107:24-32. doi: 10.1016/j.clinbiochem.2022.06.002. Epub 2022 Jun 9.
10
Age-Dependent Biomarkers for Prediction of In-Hospital Mortality in COVID-19 Patients.用于预测COVID-19患者院内死亡率的年龄依赖性生物标志物
J Clin Med. 2022 May 10;11(10):2682. doi: 10.3390/jcm11102682.
Zotero 插件